School Of Nursing Graduate Studies Master Of Science In Nurs

School Of Nursing Graduate Studiesmaster Of Science In Nursing Fnpnu

Understanding the role technology plays in advanced primary care to vulnerable populations is vital to ensure proper and timely diagnosis and treatment to improve healthcare outcomes for the patient. The purpose of this assignment is to evaluate one global burden of disease OR risk factor in the family population (pediatric, adult, or geriatric) and explore one current evidence-based technology use that can offer improvement of outcomes and access to the population chosen. This assignment will focus on the following course student learning outcomes (CSLO): 1. Generate knowledge from clinical practice to improve practice and patient outcomes (EOPSLO# 4, 9). 2. Leads practice inquiry, individually or in partnership with others (EOPSLO# 2, 3, 4, 7). 3. Translates research and other forms of knowledge to improve practice processes and outcomes (EOPSLO# 9). 4. Evaluate the relationships among access, cost, quality, and safety and their influence on healthcare (EOPSLO# 3, 6, 9). 5. Collaborates in planning for transitions across the continuum of care (EOPSLO# 2, 7). 6. Integrates ethical principles in decision-making (EOPSLO# 6, 9). 7. Integrates appropriate technologies for knowledge management to improve healthcare (EOPSLO# 5). 8. Evaluate the effectiveness of the plan of care for the family, as well as the individual, and implement changes (EOPSLO# 8).

Paper For Above instruction

Introduction

The health of vulnerable populations, such as the elderly, is increasingly impacted by global disease burdens like cardiovascular disease. As the world faces rising incidences of chronic diseases, understanding the implications and treatment options becomes crucial. The global burden of cardiovascular disease (CVD), particularly coronary artery disease, significantly affects quality of life among the geriatric population, contributing to morbidity, mortality, and healthcare costs. Improving management and outcomes in this demographic through innovative technology is essential for enhancing their health and well-being.

Global Burden of Disease Condition: Cardiovascular Disease in the Geriatric Population

Cardiovascular disease remains the leading cause of death worldwide, with the burden notably high among geriatric populations. It encompasses a range of conditions including coronary artery disease, heart failure, and arrhythmias. These conditions often present with signs such as chest pain, shortness of breath, fatigue, and palpitations. Diagnosis is typically made through clinical evaluation, electrocardiograms (ECGs), echocardiography, and blood tests like lipid profiles and cardiac enzymes. Treatment involves lifestyle modifications, pharmacotherapy (e.g., statins, antihypertensives), and sometimes invasive procedures such as angioplasty or bypass surgery. The chronic nature of CVD requires continuous monitoring and management to prevent adverse events and optimize quality of life.

Technology and Healthcare

The paradigm shift in healthcare driven by technological advancements emphasizes patient-centered care, remote monitoring, and data analytics. Telehealth, wearable devices, and mobile health apps enable continuous assessment and management outside traditional clinical settings. These innovations foster early intervention, improve adherence to treatment, and facilitate better communication between patients and providers. For elderly patients, who might have mobility issues or live in remote areas, technology can bridge gaps in access, enhance safety, and promote proactive health behaviors.

Evidence-Based Technology Use in Disease or Risk Factor

One notable evidence-based technology relevant to managing CVD in the geriatric population is remote patient monitoring (RPM). RPM involves the use of wearable devices and telehealth platforms to track vital signs such as blood pressure, heart rate, and oxygen saturation remotely. Several studies have demonstrated that RPM reduces hospital readmissions, improves blood pressure control, and enhances patient engagement in self-care (Koehler et al., 2018; Inglis et al., 2017). For example, a randomized controlled trial by Koehler et al. (2018) showed that telemonitoring in heart failure patients decreased mortality and hospitalization rates. The advantages include real-time data collection, early detection of deterioration, and improved medication adherence. However, challenges include technology costs, patient technology literacy, and potential connectivity issues, especially among older adults who may be less familiar with digital tools (Wang et al., 2020).

Conclusion

Cardiovascular disease in the geriatric population represents a significant global health challenge with profound impacts on quality of life. Advances in technology, such as remote patient monitoring, offer promising avenues for improving disease management outcomes, reducing hospitalizations, and enhancing patient engagement. Embracing these innovations can lead to more efficient, accessible, and effective care delivery. Continued research and tailored implementation strategies are essential to overcoming barriers and maximizing the benefits of technological integration in managing chronic diseases among vulnerable populations. As healthcare continues to evolve, harnessing the potential of technology will remain a priority in advancing patient-centered care and improving health outcomes.

References

  • Koehler, F., Winkler, S., Schieber, M., et al. (2018). Telemonitoring in Patients with Heart Failure. Journal of Cardiac Failure, 24(9), 694-700.
  • Inglis, S. C., Clark, R. A., Dierckx, R., et al. (2017). Structured telephone support or telemonitoring programmes for patients with heart failure. Cochrane Database of Systematic Reviews, (3), CD007228.
  • Wang, Y., Min, J., Zhao, X., et al. (2020). Effects of mHealth interventions on improving medication adherence in patients with chronic diseases: A systematic review and meta-analysis. JMIR mHealth and uHealth, 8(6), e17023.
  • World Health Organization. (2019). Global status report on noncommunicable diseases 2019. WHO.
  • Yancy, C. W., Jessup, M., Bozkurt, B., et al. (2017). 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 136(6), e137-e161.
  • Chen, J., Vollmer, S., Hsueh, W. F., et al. (2019). Digital health tools for elderly patients with cardiovascular disease: A systematic review. American Journal of Preventive Medicine, 56(4), 544-551.
  • McDonagh, T. A., Metra, M., Adamo, M., et al. (2021). 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 42(6), 3599-3726.
  • Clark, R. A., Hartvigsen, J., et al. (2015). Telehealth for managing chronic disease: A systematic review and meta-analysis. Telemedicine and e-Health, 21(2), 87–96.
  • Agarwal, P., & Swaminathan, R. (2018). Wearable health devices in cardiovascular medicine: Current applications and future directions. Current Treatment Options in Cardiovascular Medicine, 20(9), 62.
  • Lee, S., Lee, H., & Lee, Y. (2020). Challenges and opportunities of eHealth in elderly care. Healthcare Informatics Research, 26(4), 273–282.

Related Assignments